Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 140th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
CGTX	COGNITION THERAPEUTICS INC	$36.33M	-194.40%	-115.10%	-265.18%	672.20%	0.92	2.09	N/A	N/A	N/A
IMUX	IMMUNIC INC	$90.07M	-326.90%	-181.30%	1,898.68%	558.80%	-4.88	0.74	N/A	N/A	N/A
AVBP	ARRIVENT BIOPHARMA INC	$667.49M	-49.30%	-46.70%	-62.93%	-154.70%	0.06	14.34	N/A	N/A	N/A
OCS	OCULIS HOLDING AG	$980.09M	-92.70%	-69.90%	-62.07%	-169.90%	0.26	4.79	100.00%	-13,737.90%	-13,649.68%
NGNE	NEUROGENE INC	$310.49M	-36.20%	-32.50%	-26.84%	-53.80%	0.08	21.03	N/A	N/A	N/A
SNDX	SYNDAX PHARMACEUTICALS INC	$853.59M	-101.60%	-58.40%	-58.28%	-60.20%	1.98	5.80	96.10%	-757.50%	-727.96%
GPCR	STRUCTURE THERAPEUTICS INC	$1.02B	-16.30%	-15.70%	-17.22%	-21.40%	0.05	23.29	N/A	N/A	N/A
INBX	INHIBRX BIOSCIENCES INC	$317.31M	1,101.20%	762.10%	869.86%	10,965.20%	1.57	5.12	100.00%	861,485.50%	865,511.50%
ENGN	ENGENE HOLDINGS INC	$193.69M	-32.60%	-28.30%	-30.82%	-49.30%	0.17	12.67	N/A	N/A	N/A
RVMD	REVOLUTION MEDICINES INC	$6.94B	-37.10%	-32.80%	-31.64%	-41.40%	0.14	13.46	N/A	N/A	N/A
PLRZ	POLYRIZON LTD	$20.97k	-60.60%	-50.60%	-24.63%	-2,578.20%	0.05	10.17	N/A	N/A	N/A
CYTK	CYTOKINETICS INC	$4.50B	N/A	-43.70%	-52.14%	-29.40%	-5.75	5.99	100.00%	-3,201.50%	-2,996.11%
HOWL	WEREWOLF THERAPEUTICS INC	$54.30M	-89.40%	-54.90%	-70.63%	-165.10%	0.87	8.10	100.00%	-6,335.20%	-5,905.07%
PRME	PRIME MEDICINE INC	$491.04M	-125.10%	-66.30%	-68.79%	-97.60%	2.07	4.78	100.00%	-5,252.50%	-5,255.98%
TPST	TEMPEST THERAPEUTICS INC	$26.62M	-305.50%	-119.70%	-230.10%	-316.80%	1.89	1.70	N/A	N/A	N/A
OCUL	OCULAR THERAPEUTIX INC	$1.84B	-58.80%	-41.20%	-48.97%	-183.60%	0.53	10.22	90.70%	-323.10%	-302.12%
SLXN	SILEXION THERAPEUTICS CORP	$8.66M	N/A	-319.50%	-207.97%	-362.70%	2.21	3.22	N/A	N/A	N/A
ALMS	ALUMIS INC	$225.24M	-406.30%	-107.30%	-170.95%	-245.10%	0.55	3.73	100.00%	-1,974.50%	-1,974.51%
CTNM	CONTINEUM THERAPEUTICS INC	$152.64M	-24.60%	-23.50%	-26.32%	-29.70%	0.07	21.47	N/A	N/A	N/A
ZNTL	ZENTALIS PHARMACEUTICALS INC	$99.29M	-65.50%	-51.00%	-66.99%	-59.00%	0.30	6.94	100.00%	552.70%	552.64%
BCTX	BRIACELL THERAPEUTICS CORP	$5.05M	-475.70%	-184.00%	33.59%	-399.30%	0.42	3.41	N/A	N/A	N/A
SAVA	CASSAVA SCIENCES INC	$101.45M	-46.30%	-38.00%	-57.00%	2,207.70%	0.10	9.08	N/A	N/A	N/A
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$113.43M	-36.90%	-32.90%	-38.39%	-39.80%	0.10	11.82	N/A	N/A	N/A
MNMD	MIND MEDICINE (MINDMED) INC	$691.64M	-50.20%	-39.40%	-48.51%	-120.40%	0.43	4.98	N/A	N/A	N/A
DNTH	DIANTHUS THERAPEUTICS INC	$664.75M	-29.30%	-27.90%	-30.38%	-40.00%	0.06	15.99	100.00%	-1,544.00%	-1,544.02%
NKTR	NEKTAR THERAPEUTICS	$268.98M	-262.10%	-43.90%	-57.01%	-34.20%	17.65	3.24	74.60%	-152.50%	-121.08%
MIST	MILESTONE PHARMACEUTICALS INC	$77.52M	-329.60%	-67.10%	-98.69%	-48.30%	-11.11	4.67	N/A	N/A	N/A
VERA	VERA THERAPEUTICS INC	$1.33B	-40.60%	-34.50%	-28.55%	-34.30%	0.14	27.68	N/A	N/A	N/A
RNA	AVIDITY BIOSCIENCES INC	$4.42B	-27.00%	-24.60%	-26.87%	-34.70%	0.10	16.91	100.00%	-4,136.00%	-4,136.00%
CDXS	CODEXIS INC	$222.02M	-118.50%	-53.40%	-58.90%	-47.00%	1.60	3.72	71.60%	-149.50%	-127.68%
IMVT	IMMUNOVANT INC	$2.75B	-80.60%	-71.90%	-58.37%	2,444.00%	0.10	11.16	N/A	N/A	N/A
AGIO	AGIOS PHARMACEUTICALS INC	$2.16B	50.30%	46.10%	47.25%	54.50%	0.06	18.50	87.50%	1,798.30%	1,917.72%
CTXR	CITIUS PHARMACEUTICALS INC	$14.10M	-61.20%	-37.80%	-57.58%	-62.70%	0.96	0.37	N/A	N/A	N/A
ATNM	ACTINIUM PHARMACEUTICALS INC	$50.85M	-129.60%	-57.30%	-73.96%	1,572.10%	1.67	9.35	N/A	N/A	N/A
BHVN	BIOHAVEN LTD	$1.54B	-257.10%	-164.00%	-301.05%	-336.50%	0.77	2.33	N/A	N/A	N/A
ZURA	ZURA BIO LTD	$86.62M	-41.80%	-34.00%	-41.01%	370.40%	0.15	8.14	N/A	N/A	N/A
PYXS	PYXIS ONCOLOGY INC	$69.38M	-69.60%	-54.70%	-80.20%	-67.00%	0.32	7.75	N/A	N/A	N/A
CDT	CONDUIT PHARMACEUTICALS INC	$1.42M	N/A	-435.60%	-643.09%	6,952.40%	1.73	1.31	N/A	N/A	N/A
ADVM	ADVERUM BIOTECHNOLOGIES INC	$49.93M	-149.70%	-76.00%	-136.07%	-91.80%	4.21	3.57	100.00%	-15,315.90%	-15,315.90%
PLRX	PLIANT THERAPEUTICS INC	$89.62M	-67.60%	-52.50%	-68.28%	-59.60%	0.34	11.03	N/A	N/A	N/A
RCUS	ARCUS BIOSCIENCES INC	$966.73M	-70.60%	-33.00%	-40.04%	-46.00%	1.18	5.37	100.00%	-277.30%	-273.76%
WVE	WAVE LIFE SCIENCES LTD	$1.29B	-78.40%	-41.50%	-78.74%	302.50%	0.76	2.56	100.00%	-138.20%	-138.24%
DYN	DYNE THERAPEUTICS INC	$1.40B	-64.10%	-56.80%	-60.04%	-163.20%	0.28	16.83	N/A	N/A	N/A
ATXS	ASTRIA THERAPEUTICS INC	$390.52M	-33.30%	-31.30%	-36.88%	-41.00%	0.07	17.39	N/A	N/A	N/A
ACHV	ACHIEVE LIFE SCIENCES INC	$90.53M	-176.10%	-103.30%	-220.53%	-133.50%	1.66	3.51	N/A	N/A	N/A
DSGN	DESIGN THERAPEUTICS INC	$219.69M	-22.90%	-22.00%	-24.52%	-25.40%	0.04	28.37	N/A	N/A	N/A
KPTI	KARYOPHARM THERAPEUTICS INC	$32.92M	N/A	-36.00%	-53.47%	-8.80%	-1.62	1.33	96.20%	-44.00%	-14.05%
BMEA	BIOMEA FUSION INC	$62.37M	-197.70%	-134.80%	-365.02%	-1,898.50%	0.92	2.26	N/A	N/A	N/A
DNLI	DENALI THERAPEUTICS INC	$2.01B	-35.90%	-32.40%	-38.48%	-36.00%	0.13	9.56	N/A	N/A	N/A
TNGX	TANGO THERAPEUTICS INC	$654.70M	-62.80%	-39.90%	-55.40%	-48.70%	0.65	6.26	100.00%	-322.70%	-322.17%
FBLG	FIBROBIOLOGICS INC	$26.68M	-609.20%	-101.20%	-448.93%	-1,214.30%	15.17	0.93	N/A	N/A	N/A
CBUS	CIBUS INC	$50.89M	-203.20%	-68.40%	-76.61%	-92.90%	3.72	1.23	100.00%	-5,784.90%	-5,063.86%
MRSN	MERSANA THERAPEUTICS INC	$34.15M	N/A	-48.90%	-128.79%	-226.00%	-4.64	1.83	100.00%	-217.60%	-205.68%
DTIL	PRECISION BIOSCIENCES INC	$52.67M	-35.90%	-15.20%	-18.23%	-54.20%	1.52	6.63	100.00%	-43.00%	-39.94%
KALV	KALVISTA PHARMACEUTICALS INC	$680.87M	-134.10%	-82.70%	-84.76%	-166.60%	1.63	5.35	N/A	N/A	N/A
PRAX	PRAXIS PRECISION MEDICINES INC	$1.10B	-50.40%	-46.70%	-48.40%	-85.00%	0.09	8.44	100.00%	-2,617.10%	-2,617.11%
KAPA	KAIROS PHARMA LTD	$15.16M	-112.60%	-71.80%	-49.33%	-290.40%	0.11	7.52	N/A	N/A	N/A
PEPG	PEPGEN INC	$44.83M	-81.30%	-63.70%	-96.09%	-94.40%	0.39	4.95	N/A	N/A	N/A
REPL	REPLIMUNE GROUP INC	$541.92M	-58.00%	-45.20%	-48.87%	-54.70%	0.33	7.95	N/A	N/A	N/A
CRDF	CARDIFF ONCOLOGY INC	$157.67M	-78.00%	-63.70%	-86.37%	-119.30%	0.29	4.42	100.00%	-9,348.50%	-9,344.14%
NMRA	NEUMORA THERAPEUTICS INC	$317.03M	-84.80%	-77.60%	-112.88%	-195.80%	0.12	8.98	N/A	N/A	N/A
CVKD	CADRENAL THERAPEUTICS INC	$20.49M	-244.90%	-181.90%	-209.93%	887.10%	0.30	4.32	N/A	N/A	N/A
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$595.90M	-46.20%	-13.90%	-13.50%	-17.10%	1.43	5.96	37.30%	-67.30%	-50.06%
WINT	WINDTREE THERAPEUTICS INC	$2.47M	-294.40%	-72.90%	-78.51%	341.50%	1.50	0.25	N/A	N/A	N/A
LXEO	LEXEO THERAPEUTICS INC	$157.02M	-85.90%	-68.50%	-115.09%	-255.70%	0.43	3.42	N/A	N/A	N/A
BCYC	BICYCLE THERAPEUTICS PLC	$590.04M	-25.10%	-20.90%	-25.14%	-491.60%	0.19	14.86	100.00%	-790.10%	-807.73%
VKTX	VIKING THERAPEUTICS INC	$3.66B	-20.00%	-19.40%	-21.55%	-20.80%	0.04	25.86	N/A	N/A	N/A
CYBN	CYBIN INC	$166.11M	-44.70%	-42.70%	-47.70%	-769.80%	0.09	7.75	N/A	N/A	N/A
DWTX	DOGWOOD THERAPEUTICS INC	$9.24M	-9,067.90%	-48.20%	-23.03%	-682.80%	2.01	7.43	N/A	N/A	N/A
LRMR	LARIMAR THERAPEUTICS INC	$221.54M	-52.50%	-46.10%	-64.33%	-59.70%	0.18	7.48	N/A	N/A	N/A
CHRS	COHERUS BIOSCIENCES INC	$108.98M	N/A	-26.20%	-97.17%	-41.20%	-3.02	1.22	56.60%	-66.30%	-57.09%
RXRX	RECURSION PHARMACEUTICALS INC	$2.42B	-74.70%	-54.00%	-49.45%	-241.60%	0.40	4.11	6.50%	-961.30%	-962.17%
CERO	CERO THERAPEUTICS HOLDINGS INC	$3.00M	N/A	-203.00%	-8,418.30%	316.50%	-25.26	0.73	N/A	N/A	N/A
CABA	CABALETTA BIO INC	$77.13M	-78.30%	-65.70%	-95.86%	-545.60%	0.36	3.96	N/A	N/A	N/A
JSPR	JASPER THERAPEUTICS INC	$43.56M	-109.50%	-89.80%	-174.05%	2,648.80%	0.36	4.31	N/A	N/A	N/A
INDP	INDAPTUS THERAPEUTICS INC	$4.67M	-333.00%	-216.40%	-562.47%	1,251.80%	0.93	1.90	N/A	N/A	N/A
MRKR	MARKER THERAPEUTICS INC	$15.84M	-101.90%	-83.00%	-87.87%	-9,855.80%	0.17	6.79	100.00%	-224.40%	-223.57%
XCUR	EXICURE INC	$45.05M	-110.00%	-41.10%	-34.76%	-79.40%	0.82	2.91	N/A	N/A	N/A
IMA	IMAGENEBIO INC	$71.98M	-24.90%	-22.50%	-25.78%	-34.00%	0.09	13.52	N/A	N/A	N/A
PLUR	PLURI INC	$41.43M	N/A	-57.80%	N/A	-44.70%	N/A	N/A	52.10%	-2,003.30%	-2,082.79%
IGMS	IGM BIOSCIENCES INC	$76.35M	-318.00%	-71.40%	-111.29%	-82.30%	295.40	5.71	100.00%	-7,417.80%	-7,417.79%
VIGL	VIGIL NEUROSCIENCE INC	$375.71M	-111.70%	-74.70%	-113.01%	-148.00%	0.65	2.97	N/A	N/A	N/A
ATHE	ALTERITY THERAPEUTICS LTD	$53.84M	-155.80%	-120.90%	-252.18%	-452.10%	0.36	3.84	100.00%	-531.30%	-530.10%
IGC	IGC PHARMA INC	$30.20M	-102.30%	-73.40%	-109.72%	-175.80%	0.38	1.28	48.70%	-560.30%	-560.27%
GDTC	CYTOMED THERAPEUTICS LTD	$21.70M	-24.90%	-22.40%	-26.39%	-62.80%	0.11	9.89	75.40%	-3,621.10%	-3,591.88%
SNSE	SENSEI BIOTHERAPEUTICS INC	$9.43M	-69.00%	-59.00%	-87.62%	-82.00%	0.20	6.82	N/A	N/A	N/A
HOOK	HOOKIPA PHARMA INC	$10.88M	-120.60%	-77.50%	-164.55%	-402.20%	0.80	3.61	100.00%	-784.00%	-785.15%
STTK	SHATTUCK LABS INC	$36.50M	-79.70%	-69.10%	-101.08%	-185.10%	0.14	9.08	100.00%	-1,533.00%	-1,532.96%
GRCE	GRACE THERAPEUTICS INC	$39.96M	-16.30%	-14.30%	-18.22%	897.20%	0.08	11.77	N/A	N/A	N/A
PRLD	PRELUDE THERAPEUTICS INC	$44.04M	-89.20%	-69.30%	-105.23%	-83.60%	0.37	5.18	N/A	N/A	N/A
GNTA	GENENTA SCIENCE SPA	$70.34M	-54.10%	-48.00%	-70.04%	-71.10%	0.19	6.89	N/A	N/A	N/A
SPRC	SCISPARC LTD	$2.95M	79.70%	58.40%	74.02%	127.40%	0.17	5.36	38.70%	481.20%	507.12%
MTVA	METAVIA INC	$11.84M	-222.10%	-123.90%	-555.78%	309.20%	1.77	1.55	N/A	N/A	N/A
TRAW	TRAWS PHARMA INC	$8.57M	N/A	-193.20%	-399.54%	492.40%	2.18	1.81	100.00%	-15,245.80%	-15,245.81%
NAUT	NAUTILUS BIOTECHNOLOGY INC	$95.99M	-32.50%	-27.90%	-32.03%	-28.20%	0.18	18.52	N/A	N/A	N/A
VALN	VALNEVA SE	$596.81M	-43.40%	-16.40%	-14.69%	-13.40%	1.75	2.70	46.60%	-43.20%	-29.69%
VYNE	VYNE THERAPEUTICS INC	$6.10M	-71.90%	-59.00%	-95.60%	-119.70%	0.28	4.47	100.00%	-6,974.50%	-6,973.88%
VRAX	VIRAX BIOLABS GROUP LTD	$3.52M	-109.60%	-101.80%	-108.73%	-324.80%	0.17	7.27	-838.20%	-95,739.20%	-98,816.73%
ITOS	ITEOS THERAPEUTICS INC	$388.10M	-21.40%	-18.50%	-18.98%	-23.40%	0.17	14.13	100.00%	-373.70%	-336.72%
THTX	THERATECHNOLOGIES INC	$144.84M	N/A	-15.90%	66.69%	22.00%	-2.84	0.84	77.70%	-10.90%	9.56%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Aug 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Ptc Therapeutics (NASDAQ:PTCT)

Ptc Therapeutics (NASDAQ:PTCT) is the #1 top biotech stock out of 642 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ptc Therapeutics (NASDAQ:PTCT) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Ptc Therapeutics (NASDAQ:PTCT) has a Due Diligence Score of 35, which is 12 points higher than the biotech industry average of 23.

PTCT passed 11 out of 33 due diligence checks and has average fundamentals. Ptc Therapeutics has seen its stock return 53.94% over the past year, overperforming other biotech stocks by 122 percentage points.

Ptc Therapeutics has an average 1 year price target of $69.62, an upside of 33.59% from Ptc Therapeutics's current stock price of $52.11.

Ptc Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Ptc Therapeutics, 53.85% have issued a Strong Buy rating, 15.38% have issued a Buy, 23.08% have issued a hold, while 0% have issued a Sell rating, and 7.69% have issued a Strong Sell.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #2 top biotech stock out of 642 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 49, which is 26 points higher than the biotech industry average of 23.

PBYI passed 16 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock lose -13.25% over the past year, overperforming other biotech stocks by 54 percentage points.

Puma Biotechnology has an average 1 year price target of $7.00, an upside of 125.08% from Puma Biotechnology's current stock price of $3.11.

Puma Biotechnology stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Rigel Pharmaceuticals (NASDAQ:RIGL)

Rigel Pharmaceuticals (NASDAQ:RIGL) is the #3 top biotech stock out of 642 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Rigel Pharmaceuticals (NASDAQ:RIGL) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Rigel Pharmaceuticals (NASDAQ:RIGL) has a Due Diligence Score of 35, which is 12 points higher than the biotech industry average of 23.

RIGL passed 11 out of 33 due diligence checks and has average fundamentals. Rigel Pharmaceuticals has seen its stock return 99.05% over the past year, overperforming other biotech stocks by 167 percentage points.

Rigel Pharmaceuticals has an average 1 year price target of $39.75, an upside of 88.75% from Rigel Pharmaceuticals's current stock price of $21.06.

Rigel Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Rigel Pharmaceuticals, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 7.03%, which is 5 percentage points higher than the biotech industry average of 1.88%.

Dominari Holdings's dividend payout ratio of -7.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 3.42%, which is 2 percentage points higher than the biotech industry average of 1.88%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.2% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.77%, which is the same as the biotech industry average of 1.88%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 34.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.35% in the last day, and down -1.82% over the last week. Soligenix was the among the top gainers in the biotechnology industry, gaining 134.4% yesterday.

Soligenix shares are trading higher after the company announced positive Phase 2a proof-of-concept results for SGX945 in Behçet's Disease, demonstrating biological efficacy.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -13.25% in the past year. It has overperformed other stocks in the biotech industry by 54 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 3.9% in the past year. It has overperformed other stocks in the biotech industry by 72 percentage points.

3. United Therapeutics (NASDAQ:UTHR)

United Therapeutics (NASDAQ:UTHR) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

United Therapeutics has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

United Therapeutics's stock has dropped -12.32% in the past year. It has overperformed other stocks in the biotech industry by 55 percentage points.

Are biotech stocks a good buy now?

53.02% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 100.43% over the next year.

2.11% of biotech stocks have a Zen Rating of A (Strong Buy), 4.21% of biotech stocks are rated B (Buy), 37.26% are rated C (Hold), 36.42% are rated D (Sell), and 20% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -201.28x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Ptc Therapeutics (NASDAQ:PTCT)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Rigel Pharmaceuticals (NASDAQ:RIGL)

1. Dominari Holdings (NASDAQ:DOMH)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Puma Biotechnology (NASDAQ:PBYI)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. United Therapeutics (NASDAQ:UTHR)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Ptc Therapeutics (NASDAQ:PTCT)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Rigel Pharmaceuticals (NASDAQ:RIGL)

1. Dominari Holdings (NASDAQ:DOMH)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Puma Biotechnology (NASDAQ:PBYI)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. United Therapeutics (NASDAQ:UTHR)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.